Spain’s pharmaceutical financing advisory committee has proposed standard methods for budget-impact submissions, with a three-year base case and explicit uncertainty analysis.
Spain’s Ministry of Health has published a proposed methodological guide for budget-impact analyses used in medicines pricing and reimbursement decisions. The guide, prepared by the Advisory Committee for Pharmaceutical Financing (Comité Asesor para la Financiación de la Prestación Farmacéutica, CAPF), was published in October although the document is dated 14 July.
The guide establishes a common base case from the perspective of the National Health System (Sistema Nacional de Salud, SNS), normally covering three calendar years. It also describes when longer projections are appropriate and how to estimate eligible populations, treatment uptake, displaced therapies and changes in medicine expenditure.
Analyses should take account of relevant changes to the market, including new competitors, generic and biosimilar entry, confidential prices and expected shifts in treatment use. CAPF recommends transparent, reproducible models, explicit source data and assumptions, and uncertainty analyses covering plausible minimum and maximum expenditure outcomes.
Spain already uses budget-impact evidence in national funding decisions. CAPF previously developed a separate economic evaluation guide and recommended a more systematic approach to economic submissions. The October publication provides a detailed common method specifically for projecting the budgetary consequences of reimbursement decisions.
The guidance is advisory. CAPF recommends that the Ministry formally specify its use in pricing and funding applications and test the method during a three-to-six-month pilot. Until those steps occur, it does not impose a new mandatory dossier requirement.
The document nevertheless gives applicants and reviewers a common reference for how medicine-related budget effects should be estimated and checked.
Source: Ministry of Health, Spain
Link: Guía de Análisis de Impacto Presupuestario del Comité Asesor de la Prestación Farmacéutica (Budget Impact Analysis Guide of the Pharmaceutical Financing Advisory Committee)
Date: 14 July 2026
Source: Diariofarma
Link: Sanidad publica la propuesta del CAPF de guía de Análisis de Impacto Presupuestario (Ministry of Health publishes CAPF’s proposed budget-impact assessment guide)
Date: 15 October 2026
Please accept {{cookieConsents}} cookies to view this content